chr8-11300096-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_015458.4(MTMR9):āc.365A>Gā(p.Asp122Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,613,486 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00019 ( 0 hom., cov: 33)
Exomes š: 0.000024 ( 0 hom. )
Consequence
MTMR9
NM_015458.4 missense
NM_015458.4 missense
Scores
3
12
4
Clinical Significance
Conservation
PhyloP100: 9.11
Genes affected
MTMR9 (HGNC:14596): (myotubularin related protein 9) This gene encodes a myotubularin-related protein that is atypical to most other members of the myotubularin-related protein family because it has no dual-specificity phosphatase domain. The encoded protein contains a double-helical motif similar to the SET interaction domain, which is thought to have a role in the control of cell proliferation. In mouse, a protein similar to the encoded protein binds with MTMR7, and together they dephosphorylate phosphatidylinositol 3-phosphate and inositol 1,3-bisphosphate. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MTMR9 | NM_015458.4 | c.365A>G | p.Asp122Gly | missense_variant | 3/10 | ENST00000221086.8 | |
MTMR9 | XM_047422125.1 | c.365A>G | p.Asp122Gly | missense_variant | 3/11 | ||
MTMR9 | XM_017013753.3 | c.365A>G | p.Asp122Gly | missense_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MTMR9 | ENST00000221086.8 | c.365A>G | p.Asp122Gly | missense_variant | 3/10 | 1 | NM_015458.4 | P1 | |
MTMR9 | ENST00000530200.1 | c.*111A>G | 3_prime_UTR_variant, NMD_transcript_variant | 4/11 | 1 | ||||
MTMR9 | ENST00000526292.1 | c.110A>G | p.Asp37Gly | missense_variant | 3/10 | 2 | |||
MTMR9 | ENST00000528389.1 | n.602A>G | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152116Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
29
AN:
152116
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251352Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135848
GnomAD3 exomes
AF:
AC:
11
AN:
251352
Hom.:
AF XY:
AC XY:
5
AN XY:
135848
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1461370Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 726974
GnomAD4 exome
AF:
AC:
35
AN:
1461370
Hom.:
Cov.:
31
AF XY:
AC XY:
20
AN XY:
726974
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000191 AC: 29AN: 152116Hom.: 0 Cov.: 33 AF XY: 0.000229 AC XY: 17AN XY: 74314
GnomAD4 genome
AF:
AC:
29
AN:
152116
Hom.:
Cov.:
33
AF XY:
AC XY:
17
AN XY:
74314
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2022 | The c.365A>G (p.D122G) alteration is located in exon 3 (coding exon 3) of the MTMR9 gene. This alteration results from a A to G substitution at nucleotide position 365, causing the aspartic acid (D) at amino acid position 122 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;.
Vest4
MutPred
Loss of catalytic residue at D122 (P = 0.0711);.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at